Healthcare -
Biotechnology - NASDAQ - US
$ 24.05
-4.37 %
$ 2.99 B
Market Cap
-15.03
P/E
APLS - FREE CASH FLOW
Free Cash Flow APLS - Apellis Pharmaceuticals, Inc.
-596 M
LAST VALUE
-2.73%
2 YEAR CAGR
-35.32%
5 YEAR CAGR
-67.41%
10 YEAR CAGR